Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration

Neurobiology of Disease

Volumn 24, Issue 3, 2006, Pages 525-530

  Melli, Giorgia ^a   Jack, Christelene ^a   Lambrinos, George L ^a   Ringkamp, Mathias ^a   Höke, Ahmet ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal degeneration; Chemotherapy; Detyrosinated tubulin; Distal axonopathy; Erythropoietin; Paclitaxel

Indexed keywords

PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EMBRYO; FEMALE; IN VITRO STUDY; MOUSE; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SENSORY NERVE CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AXONS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ERYTHROPOIETIN; FEMALE; GANGLIA, SPINAL; GLYCEROL; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; NERVE DEGENERATION; NEURONS, AFFERENT; NEUROPROTECTIVE AGENTS; PACLITAXEL; RECOMBINANT PROTEINS; TUBULIN; TYROSINE;

EID: 33750839552     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.08.014     Document Type: Article

References (42)

1. Apfel S.C., Lipton R.B., Arezzo J.C., and Kessler J.A. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol. 29 (1991) 87-90
2. Authier N., Gillet J.P., Fialip J., Eschalier A., and Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res. 887 (2000) 239-249
3. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., and Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 823-828
4. Campana W.M., and Myers R.R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. 15 (2001) 1804-1806
5. Campana W.M., and Myers R.R. Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur. J. Neurosci. 18 (2003) 1497-1506
6. Campana W.M., Eskeland N., Calcutt N.A., Misasi R., Myers R.R., and O'Brien J.S. Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology 19 (1998) 237-244
7. Cavaletti G., Tredici G., Braga M., and Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 133 (1995) 64-72
8. Cavaletti G., Bogliun G., Marzorati L., Zincone A., Marzola M., Colombo N., and Tredici G. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin. Cancer 75 (1995) 1141-1150
9. Chaudhry V., Rowinsky E.K., Sartorius S.E., Donehower R.C., and Cornblath D.R. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann. Neurol. 35 (1994) 304-311
10. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
11. Digicaylioglu M., Garden G., Timberlake S., Fletcher L., and Lipton S.A. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9855-9860
12. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., Di Giulio A.M., Vardar E., Cerami A., and Brines M. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9450-9455
13. Griffin J.W., McArthur J.C., and Polydefkis M. Assessment of cutaneous innervation by skin biopsies. Curr. Opin. Neurol. 14 (2001) 655-659
14. Hamers F.P., Pette C., Neijt J.P., and Gispen W.H. The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats. Eur. J. Pharmacol. 233 (1993) 177-178
15. In: Hoke A. (Ed). Erythropoietin and the Nervous System (2006), Springer, Boston
16. Hoke A., Ho T., Crawford T.O., LeBel C., Hilt D., and Griffin J.W. Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers. J. Neurosci. 23 (2003) 561-567
17. Keswani S.C., Chander B., Hasan C., Griffin J.W., McArthur J.C., and Hoke A. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 53 (2003) 57-64
18. Keswani S.C., Leitz G.J., and Hoke A. Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci. Lett. 371 (2004) 102-105
19. Keswani S.C., Buldanlioglu U., Fischer A., Reed N., Polley M., Liang H., Zhou C., Jack C., Leitz G.J., and Hoke A. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann. Neurol 56 (2004) 815-826
20. Komiya Y. Changes of fast axonal transport by taxol injected subepineurally into the rat sciatic nerve. Neurosci. Res. 14 (1992) 159-165
21. Laferriere N.B., MacRae T.H., and Brown D.L. Tubulin synthesis and assembly in differentiating neurons. Biochem. Cell Biol. 75 (1997) 103-117
22. Li X., Gonias S.L., and Campana W.M. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia 51 (2005) 254-265
23. Lipton R.B., Apfel S.C., Dutcher J.P., Rosenberg R., Kaplan J., Berger A., Einzig A.I., Wiernik P., and Schaumburg H.H. Taxol produces a predominantly sensory neuropathy. Neurology 39 (1989) 368-373
24. Mansfield S.G., and Gordon-Weeks P.R. Dynamic post-translational modification of tubulin in rat cerebral cortical neurons extending neurites in culture: effects of taxol. J. Neurocytol. 20 (1991) 654-666
25. Mialhe A., Lafanechere L., Treilleux I., Peloux N., Dumontet C., Bremond A., Panh M.H., Payan R., Wehland J., Margolis R.L., and Job D. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res. 61 (2001) 5024-5027
26. Mimura Y., Kato H., Eguchi K., and Ogawa T. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study. Neurotoxicology 21 (2000) 513-520
27. Nakata T., and Yorifuji H. Morphological evidence of the inhibitory effect of taxol on the fast axonal transport. Neurosci. Res. 35 (1999) 113-122
28. Orhan B., Yalcin S., Nurlu G., Zeybek D., and Muftuoglu S. Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats. Med. Oncol. 21 (2004) 197-203
29. Polomano R.C., Mannes A.J., Clark U.S., and Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94 (2001) 293-304
30. Robson S.J., and Burgoyne R.D. Differential localisation of tyrosinated, detyrosinated, and acetylated alpha-tubulins in neurites and growth cones of dorsal root ganglion neurons. Cell Motil. Cytoskeleton 12 (1989) 273-282
31. Rowinsky E.K., Eisenhauer E.A., Chaudhry V., Arbuck S.G., and Donehower R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin. Oncol. 20 (1993) 1-15
32. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
33. Sahenk Z., Barohn R., New P., and Mendell J.R. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch. Neurol. 51 (1994) 726-729
34. Schiff P.B., and Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 1561-1565
35. Shea T.B. Selective stabilization of microtubules within the proximal region of developing axonal neurites. Brain Res. Bull. 48 (1999) 255-261
36. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4044-4049
37. Smith S.B., Crager S.E., and Mogil J.S. Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains. Life Sci. 74 (2004) 2593-2604
38. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., and Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198 (2003) 971-975
39. Wang M.S., Davis A.A., Culver D.G., and Glass J.D. WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann. Neurol. 52 (2002) 442-447
40. Wang M.S., Davis A.A., Culver D.G., Wang Q., Powers J.C., and Glass J.D. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127 (2004) 671-679
41. Windebank A.J. The vehicle for cyclosporine is neurotoxic in vitro. Ann. Neurol. 41 (1997) 563-564
42. Windebank A.J., Blexrud M.D., and de Groen P.C. Potential neurotoxicity of the solvent vehicle for cyclosporine. J. Pharmacol. Exp. Ther. 268 (1994) 1051-1056